Sabaa International Company for Pharmaceutical and Chemical Industry (EGX: SIPC)

Market Cap	365.00M
Revenue (ttm)	15.56M
Net Income (ttm)	-8.61M
Shares Out	250.00M
EPS (ttm)	-0.03
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,620,614
Open	1.470
Previous Close	1.470
Day's Range	1.430 - 1.500
52-Week Range	0.615 - 1.850
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 13, 2024

About SIPC

Sabaa International Company for Pharmaceutical and Chemical Industry engages in the manufacture and sale of generic medicines in Egypt. It offers hard gelatin capsules, such as Acitretin; film coated tablets, including Saboctic, Topiramate, and Tolterodine; and tablets, such as Claudol and Flamogen E.C.T. The company also provides OTCs, food supplements, and veterinary products, as well as medicine trials services. The company was founded in 2000 and is based in Cairo, Egypt.

• Industry: Pharmaceutical Preparations
• Founded: 2000
• Employees: 165
• Stock Exchange: Egyptian Stock Exchange
• Ticker Symbol: SIPC

Financial Performance

In 2023, SIPC's revenue was 13.31 million, a decrease of -26.88% compared to the previous year's 18.20 million. Earnings were 113,086, an increase of 670.55%.